NCT06766799

Brief Summary

To compare the accuracy between handheld rebound tonometer \& applanation tonometer in IOP measurement in pediatric glaucoma cases

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 5, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 9, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 9, 2025

Status Verified

January 1, 2025

Enrollment Period

8 months

First QC Date

January 5, 2025

Last Update Submit

January 5, 2025

Conditions

Glaucoma

Outcome Measures

Primary Outcomes (1)

  • Comparison between the IOP Measurments by Rebound Tonometer & Applanation tonometer

    To compare the accuracy between handheld rebound tonometer \& applanation tonometer in IOP measurement in pediatric glaucoma cases

    over nine months

Study Arms (2)

Group A ( Glaucomatous Patients)

Device: Rebound and Applanation Tonometer

Group B ( Control Group)

Device: Rebound and Applanation Tonometer

Interventions

Rebound and Applanation TonometerDEVICE

Measurement of Intraocular Pressure

Group A ( Glaucomatous Patients)Group B ( Control Group)

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

100 Cases of Glaucomatous Patients and 60 Cases of Healthy Individuals

You may qualify if:

  • Patients attending to our pediatric glaucoma clinic diagnosed with glaucoma aged \>18 years old are subjected to IOP Measurements.

You may not qualify if:

  • \*\*Patients aged more than 18 years old
  • patients with scarred cornea

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Doctor

Study Record Dates

First Submitted

January 5, 2025

First Posted

January 9, 2025

Study Start

March 1, 2025

Primary Completion

November 1, 2025

Study Completion

December 1, 2025

Last Updated

January 9, 2025

Record last verified: 2025-01